University of Pavia

unipv.it

Total trials

134

Active

28

Phase 3

5

Total enrollment

18,084

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 8 of 8 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Whole Genome Sequencing1
Sterify Gel1
Para-probiotic oral care1
Chlorhexidine oral care1
Lactoferrin-based Toothpaste and Mouthwash1
Lactoferrin-Based Toothpaste Only1
Biorepair® Total Protection Plus Toothpaste1
Bioniq® Toothpaste1

Next readouts

  • 2026-05-05
  • 2026-06-01
  • 2026-06-01
  • 2026-06-01
  • 2027-04

Top conditions

  • Periodontal Diseases10
  • Peri-implant Mucositis8
  • Hypertension6
  • Dental Plaque4
  • Essential Hypertension4
  • Dental Caries4
  • Malnutrition4
  • Dyslipidemias4

Frequently asked questions about University of Pavia

How many clinical trials does University of Pavia have on ClinicalTrials.gov?
University of Pavia is listed as the lead sponsor on 134 clinical trials in ClinicalTrials.gov, 28 of which are currently active (recruiting, enrolling, or ongoing).
How many of University of Pavia's trials are in Phase 3?
5 of University of Pavia's trials are in Phase 3, spread across 8 active drug programs.
What therapeutic areas does University of Pavia focus on?
University of Pavia's most-studied conditions on ClinicalTrials.gov are Periodontal Diseases, Peri-implant Mucositis, Hypertension, Dental Plaque, Essential Hypertension.
When are University of Pavia's next clinical trial readouts?
University of Pavia has 5 upcoming primary-completion readouts tracked here; the soonest is “Natural Bioactive Gel for Peri-Implantitis”, expected around 2026-05-05.